Table 6.
Cross-reactivity of FeCoV-specific antibodies with SARS-CoV-2.
Cat ID | RBD M | N M | N E | VN | IFA (SARS-CoV-2) | IFA (FeCoV) | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
FeCoV pos #1 | 0.21 | Neg | 2.17 | Pos | 2.86 | Pos | <1:20 | >1:2,400 | Pos | >1:6,400 | Pos |
FeCoV pos #2 | 0.15 | Neg | 1.29 | Pos | 1.32 | Pos | <1:20 | 1:80 | Pos | >1:6,400 | Pos |
FeCoV pos #0 | 0.18 | Neg | 1.89 | Pos | 1.53 | Pos | <1:20 | 1:80 | Pos | >1:6,400 | Pos |
FeCoV pos #3 | 0.09 | Neg | 0.2 | Neg | 0.28 | Neg | <1:20 | <1:40 | Neg | >1:6,400 | Pos |
FeCoV pos #4 | 0.11 | Neg | 0.12 | Neg | 0.31 | Neg | <1:20 | <1:40 | Neg | >1:6,400 | Pos |
FeCoV pos #5 | 0.31 | Neg | 0.26 | Neg | 0.37 | Pos | <1:20 | <1:40 | Neg | 1:3,200 | Pos |
FeCoV pos #6 | 0.12 | Neg | 0.19 | Neg | 0.53 | Pos | <1:20 | <1:40 | Neg | >1:6,400 | Pos |
FeCoV pos #7 | 0.05 | Neg | 0.15 | Neg | 0.16 | Neg | <1:20 | <1:40 | Neg | 1:3,200 | Pos |
FeCoV pos #8 | 0.07 | Neg | 0.15 | Neg | 0.12 | Neg | <1:20 | <1:40 | Neg | >1:6,400 | Pos |
FeCoV pos #27 | 0.09 | Neg | 2.63 | Pos | 1.74 | Pos | <1:20 | 1:320 | Pos | >1:6,400 | Pos |
FeCoV pos #28 | 0.28 | Neg | 2.03 | Pos | 2.41 | Pos | <1:20 | 1:320 | Pos | >1:6,400 | Pos |
FeCoV pos #29 | 0.07 | Neg | 0.97 | Pos | 1.29 | Pos | <1:20 | 1:80 | Pos | 1:3,200 | Pos |
FeCoV pos #30 | 0.22 | Neg | 2.87 | Pos | 2.26 | Pos | <1:20 | >1:1,280 | Pos | >1:6,400 | Pos |
FeCoV neg #9 | 0.23 | Neg | 0.09 | Neg | 0.55 | Neg | <1:20 | <1:40 | Neg | <1:40 | Neg |
FeCoV neg #10 | 0.07 | Neg | 0.1 | Neg | 0.21 | Neg | <1:20 | <1:40 | Neg | <1:40 | Neg |
FeCoV neg #11 | 0.27 | Neg | 0.1 | Neg | 0.24 | Neg | <1:20 | <1:40 | Neg | <1:40 | Neg |
FeCoV neg #12 | 0.14 | Neg | 0.17 | Neg | 0.41 | Neg | <1:20 | <1:40 | Neg | <1:40 | Neg |
FeCoV neg #14 | 0.09 | Neg | 0.1 | Neg | 0.1 | Neg | <1:20 | <1:40 | Neg | <1:40 | Neg |
FeCoV neg #15 | 0.1 | Neg | 0.14 | Neg | 0.17 | Neg | <1:20 | <1:40 | Neg | <1:40 | Neg |
FeCoV mAb | 0.1 | Neg | 0.27 | Neg | 0.31 | Neg | <1:20 | <1:40 | Neg | 1:400 | Pos |
FeCoV, feline coronavirus; RBDM, NM, mammalian cell-expressed RBD and N, respectively; NE, E. coli-expressed N; neg, negative; pos, positive; mAb, monoclonal antibody.